Jaguar Health, Inc. (JAGX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on April 7, 2026. The filing serves to announce the Company's financial results for the fiscal year 2025. The full details of these results are contained in a press release furnished as Exhibit 99.1 to this report.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the accompanying press release (Exhibit 99.1), which is not included in the provided source text.
Material Changes
No specific material changes versus prior periods are quantified in the body of this 8-K filing. The document solely acts as a notification that 2025 results have been issued.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in Item 2.02 and the press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to its liabilities, except as expressly set forth by specific reference. No specific guidance, outlook, or risk factors are detailed in the text of this report.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 7, 2026) for actual 2025 financial figures.
- Verify the specific revenue and net loss figures for the 2025 fiscal year.
- Check for any updated forward-looking guidance or operational milestones mentioned in the press release.
- Confirm the Company's cash position and runway as disclosed in the full press release.